Furrer Rémy A, Merner Amanda R, Stevens Ian, Zuk Peter, Williamson Theresa, Shen Francis X, Lázaro-Muñoz Gabriel
Department of Neurosurgery, Massachusetts General Hospital.
Harvard Medical School.
Device. 2025 May 22. doi: 10.1016/j.device.2025.100804.
Public attitudes toward four neurotechnologies for treating three types of brain disorders (mood, motor, and memory) vary on a range of metrics such as perceived risk, invasiveness, and likelihood of use. In a survey of 1,052 U.S. participants, deep brain stimulation (DBS) was seen as the most invasive and risky among the surveyed methods, involving the greatest perceived change to the person and the least likely to be used personally. Non-surgical options like transcranial magnetic stimulation (TMS) and pills were viewed as more acceptable. Devices targeting motor symptoms were rated as more beneficial and acceptable than those for mood or memory. These findings highlight barriers to adoption and the need to address public perceptions, ensure patients are informed, and promote ethical implementation of these technologies.
公众对用于治疗三种脑部疾病（情绪、运动和记忆）的四种神经技术的态度，在一系列指标（如感知风险、侵入性和使用可能性）上存在差异。在一项对1052名美国参与者的调查中，深部脑刺激（DBS）在被调查的方法中被视为侵入性最强和风险最高的，涉及对人的最大感知变化，且个人使用可能性最小。像经颅磁刺激（TMS）和药物等非手术选择被认为更可接受。针对运动症状的设备比针对情绪或记忆的设备被评为更有益和可接受。这些发现凸显了采用这些技术的障碍，以及解决公众认知、确保患者知情并促进这些技术的道德实施的必要性。
